Table 2. Comparing epitope mapping result of HRH peptide with genuine VEGFR-binding site on ligand.
Receptor | Ligand | Complex | HRH peptide mapping results | PDB sum interface |
---|---|---|---|---|
VEGFR-1 | VEGF-A | 1FLT | K16, Q22, R23, H27, T31, L32, Q37, K48, R56, T71, T77, Q79, R82, Q89, H90, L97, Q98, H99, K101 | F17, M18, Y21, Q22, Y25, K48, D63, G65, L66, M81, I83, H86, Q89, I91, E103, C104, R105, P106 |
VEGFR-1 | VEGF-B | 2XAC | T22, T25, L35, T36, L39, T42, A44, K45, Q46, L47, Q79, L81, R84, Q89, L90 | S16, W17, Y21, T22, T25, Q27, V48, P62, D63, L66, Q79, L81, S88, Q89, L90, C103, P105 |
VEGFR-1 | PlGF | 1RV6 | R35, A36, L37, R39, L63, R64, T66, T81, A82, Q106, H107, R109 | F25, Q26, W29, G30, Y33, M54, S56, G70, D71, L74, N73, Q87, L89, I91, P97, Y99, C112, R113, P114 |
VEGFR-2 | VEGF-A | 3V2A | H27, T31, R56, L66, T71, L97, Q98, H99, K101, R105 | P40, D41, I43, E44, K48, M81, I83, P85, H86, Q89 |
VEGFR-2 | VEGF-C | 2X1W | R127, K128, Q130, R134, A137, R161, L171, Q172, T176, H206, R210 | T116, L119, D123, W126, R127, Q130, K142, T148, N149, F151, K153, N167, S168, E169, G170, F186, I188, V190, P191, L192, G195, P196, R210, K214, L215 |
Abbreviations: PlGF, placenta growth factor; VEGF, vascular endothelial growth factor; VEGFR, VEGF receptor.
Overlapping residues were in bold.